Zobrazeno 1 - 10
of 2 453
pro vyhledávání: '"Beijersbergen, R"'
Autor:
Dopler A; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Alkan F; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Malka Y; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Kammen R; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoefakker K; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Taranto D; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kocabay N; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mimpen I; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ramirez C; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Malzer E; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Isaeva OI; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kerkhoff M; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Gangaev A; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Silva J; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ramalho S; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoekman L; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Akkari L; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Yewdell JW; Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Kvistborg P; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Faller WJ; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.faller@nki.nl.
Publikováno v:
Cell [Cell] 2024 Nov 27; Vol. 187 (24), pp. 6981-6993.e23. Date of Electronic Publication: 2024 Oct 21.
Autor:
Prekovic S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., Chalkiadakis T; Center for Molecular Medicine, UMC Utrecht, Utrecht, The Netherlands., Roest M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Roden D; Cancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia., Lutz C; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schuurman K; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hoekman L; Mass Spectrometry/Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Abbott N; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Tesselaar T; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wajahat M; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Dwyer AR; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Mayayo-Peralta I; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gomez G; School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons University of Medicine and Health Sciences, Dublin, Ireland., Altelaar M; Mass Spectrometry/Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis and Robotics and Screening Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands., Győrffy B; TTK Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.; Department of Bioinformatics and 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary., Young L; Endocrine Oncology Research Group, Department of Surgery, The Royal College of Surgeons University of Medicine and Health Sciences, Dublin, Ireland.; Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland., Linn S; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jonkers J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Tilley W; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.; Freemasons Centre for Male Health and Wellbeing, University of Adelaide, Adelaide, SA, Australia., Hickey T; Dame Roma Mitchell Cancer Research Laboratories, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia., Vareslija D; School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons University of Medicine and Health Sciences, Dublin, Ireland.; Beaumont RCSI Cancer Centre, Beaumont Hospital, Dublin, Ireland., Swarbrick A; Cancer Ecosystems Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2023 Dec 07; Vol. 15 (12), pp. e17737. Date of Electronic Publication: 2023 Oct 30.
Autor:
Pandey GK; Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Landman N; Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Neikes HK; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Hulsman D; Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands., Lieftink C; Division of Molecular Carcinogenesis, NKI Robotics and Screening Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis, NKI Robotics and Screening Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kolluri KK; Lung for Living Research Centre, UCL Respiratory, University College London, Rayne Building, London, UK., Janes SM; Lung for Living Research Centre, UCL Respiratory, University College London, Rayne Building, London, UK., Vermeulen M; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Badhai J; Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: j.badhai@nki.nl., van Lohuizen M; Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: m.v.lohuizen@nki.nl.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2023 Feb 21; Vol. 4 (2), pp. 100915. Date of Electronic Publication: 2023 Jan 18.
Autor:
Mayayo-Peralta I; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Faggion B; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Hoekman L; Proteomics Facility, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Morris B; Division of Molecular Carcinogenesis and Robotics and Screening Centre, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., Lieftink C; Division of Molecular Carcinogenesis and Robotics and Screening Centre, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., Goldsbrough I; Department of Surgery & Cancer, Imperial College London, London SW7 2BX, UK., Buluwela L; Department of Surgery & Cancer, Imperial College London, London SW7 2BX, UK., Siefert JC; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Post H; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CS Utrecht, The Netherlands., Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CS Utrecht, The Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis and Robotics and Screening Centre, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands., Ali S; Department of Surgery & Cancer, Imperial College London, London SW7 2BX, UK., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, 5612 AZ Eindhoven, The Netherlands., Prekovic S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 16; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 16.
Autor:
Prekovic S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.prekovic@nki.nl., Schuurman K; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mayayo-Peralta I; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Manjón AG; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Buijs M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Yavuz S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wellenstein MD; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Barrera A; Department of Biostatistics & Bioinformatics, and Centre for Genomic & Computational Biology, Duke University Medical Centre, Durham, NC, USA., Monkhorst K; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huber A; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia., Morris B; Division of Molecular Carcinogenesis and Robotics and Screening Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands., Lieftink C; Division of Molecular Carcinogenesis and Robotics and Screening Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands., Chalkiadakis T; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Alkan F; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Silva J; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Győrffy B; Semmelweis University Department of Bioinformatics and 2nd Department of Pediatrics, Budapest, Hungary.; TTK Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary., Hoekman L; Mass spectrometry/Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek B; Division of Cell Biology and BioImaging Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Teunissen H; Division of Gene Regulation, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Debets DO; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Severson T; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jonkers J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Reddy T; Department of Biostatistics & Bioinformatics, and Centre for Genomic & Computational Biology, Duke University Medical Centre, Durham, NC, USA., de Visser KE; Division of Tumour Biology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Faller W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis and Robotics and Screening Centre, Netherlands Cancer Institute, Amsterdam, The Netherlands., Altelaar M; Mass spectrometry/Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., de Wit E; Division of Gene Regulation, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Medema R; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.zwart@nki.nl.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. w.zwart@nki.nl.
Publikováno v:
Nature communications [Nat Commun] 2021 Jul 16; Vol. 12 (1), pp. 4360. Date of Electronic Publication: 2021 Jul 16.
Autor:
Palit SAL; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.palit@nki.nl., van Dorp J; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Vis D; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Lieftink C; NKI Robotics and Screening Center and ScreeninC, Netherlands Cancer Institute, Amsterdam, The Netherlands., Linder S; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijersbergen R; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; NKI Robotics and Screening Center and ScreeninC, Netherlands Cancer Institute, Amsterdam, The Netherlands., Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Zwart W; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Heijden MS; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. ms.vd.heijden@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. ms.vd.heijden@nki.nl.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jul 01; Vol. 11 (1), pp. 13683. Date of Electronic Publication: 2021 Jul 01.
Autor:
Paraipan, Andreea Aura1 (AUTHOR), Gonzalez‐Hernandez, Diana2 (AUTHOR), Reddy, Innem V. A. K.2,3 (AUTHOR), Balistreri, Giacomo1 (AUTHOR), Zanotto, Luca1 (AUTHOR), Shalaby, Mostafa4 (AUTHOR), Morandotti, Roberto1 (AUTHOR), Liberale, Carlo2,5 (AUTHOR) carlo.liberale@kaust.edu.sa, Razzari, Luca1 (AUTHOR) luca.razzari@inrs.ca
Publikováno v:
Small Science. Dec2024, Vol. 4 Issue 12, p1-7. 7p.
Autor:
Deschênes, Mathieu1 (AUTHOR), Durand, Mathieu1 (AUTHOR), Olivier, Marc‐Alexandre2,3 (AUTHOR), Pellerin‐Viger, Alicia2,3 (AUTHOR), Rodier, Francis2,3,4 (AUTHOR), Chabot, Benoit1 (AUTHOR) benoit.chabot@usherbrooke.ca
Publikováno v:
Aging Cell. Nov2024, Vol. 23 Issue 11, p1-17. 17p.
Autor:
Zhang, Xia1 (AUTHOR) zx717@hunnu.edu.cn, Peng, Peng1 (AUTHOR), Bao, Li-Wei1 (AUTHOR), Zhang, An-Qi1 (AUTHOR), Yu, Bo1 (AUTHOR), Li, Tao1 (AUTHOR), Lei, Jing1 (AUTHOR), Zhang, Hui-Hui1 (AUTHOR) zhanghh87@hunnu.edu.cn, Li, Shang-Ze1,2 (AUTHOR) zhanghh87@hunnu.edu.cn
Publikováno v:
Cells (2073-4409). Nov2024, Vol. 13 Issue 21, p1798. 14p.
Autor:
Tabibian, Mobina1 (AUTHOR), Moghaddam, Fahimeh Salasar2 (AUTHOR), Motevaseli, Elahe3 (AUTHOR) e_motevaseli@tums.ac.ir, Ghafouri-Fard, Soudeh2 (AUTHOR) s.ghafourifard@sbmu.ac.ir
Publikováno v:
Cell Communication & Signaling. 10/17/2024, Vol. 22 Issue 1, p1-20. 20p.